Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;19(4):2672-2678.
doi: 10.3892/etm.2020.8483. Epub 2020 Feb 3.

Meta-analysis on the use of hyaluronic acid gel to prevent intrauterine adhesion after intrauterine operations

Fei Zheng  1 , Xin Xin  2 , Fei He  1 , Jianyong Liu  1 , Yuechong Cui  3
Affiliations

Meta-analysis on the use of hyaluronic acid gel to prevent intrauterine adhesion after intrauterine operations

Fei Zheng et al. Exp Ther Med. 2020 Apr.

Abstract

Intrauterine adhesion (IUA) is a severe complication that occurs following abortion, and hyaluronic acid gel has been used to prevent IUA following intrauterine operation. The present study aimed to systematically evaluate the efficacy of hyaluronic acid gel in preventing IUA following intrauterine operation. In the current study, a literature search was performed using PubMed, Cochrane Library and EMbase databases for randomized controlled clinical trials that used hyaluronic acid gel as an adjuvant therapy following intrauterine operation. The terms 'hyaluronic acid', 'intrauterine adhesions', 'Asherman's syndrome', 'IUA', 'dilatation and curettage', 'abortion' and 'hysteroscopic' were used to search for articles published online before July 31, 2018. RevMan 5.3 software was used to analyze the indicators of uterine cavity adhesion formation and pregnancy rates following intrauterine operation. A total of seven randomized controlled clinical studies were included, consisting of 952 patients who underwent intrauterine operation. The meta-analysis indicated that the use of hyaluronic acid gel reduced the incidence of IUA [relative risk (RR)=0.42; 95% confidence interval (CI)=0.30-0.57; P<0.001] and the score for IUA after an intrauterine operation (mean difference=-1.29; 95%=-1.73 to -0.84; P<0.001). A subgroup analysis revealed that the preventive effect of hyaluronic acid gel on IUA was not affected by the type of intrauterine operation, namely abortion (RR=0.40; 95% CI=0.26-0.62; P<0.001) and hysteroscopy (RR=0.44; 95% CI=0.28-0.68; P<0.001). The preventive effect of hyaluronic acid gel on IUA was also not affected by primary disorders/diseases including the following: Abortion (RR=0.48; 95% CI=0.29-0.78; P=0.003); IUA (RR=0.38; 95% CI=0.21-0.67; P<0.001) and submucosal myoma of the uterus, endometrial polyps or mediastinum uterus (RR=0.40; 95% CI=0.18-0.90; P=0.03). Hyaluronic acid gel improved pregnancy rates after intrauterine operations (RR=1.94; 95% CI=1.46-2.60; P<0.001). In conclusion, hyaluronic acid gel was indicated to significantly reduce the incidence of IUA following intrauterine operation, regardless of the type of intrauterine operation or the presence of primary diseases. Treatment with hyaluronic acid gel was also revealed to increase pregnancy rates following intrauterine operation.

Keywords: hyaluronic acid gel; intrauterine adhesions; intrauterine operation; pregnancy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flowchart depicting the method behind the selection of the studies.
Figure 2.
Figure 2.
Biased risk assessment chart of studies included in the meta-analysis (n=7). Green indicates a low risk of bias, yellow indicates an unclear risk of bias and red indicates a high risk of bias.
Figure 3.
Figure 3.
Forest plot of the incidence of intrauterine adhesions after intrauterine operation. CI, confidence interval; df, degrees of freedom; M-H, Mantel-Haenszel.
Figure 4.
Figure 4.
Forest plot of the intrauterine adhesion score after an intrauterine operation. CI, confidence interval; df, degrees of freedom; IV, inverse variance.
Figure 5.
Figure 5.
Forest plot of the incidence of intrauterine adhesions between abortion and hysteroscopy after an intrauterine operation. CI, confidence interval; df, degrees of freedom; M-H, Mantel-Haenszel.
Figure 6.
Figure 6.
Forest plot of the incidence of postoperative intrauterine adhesion of different primary diseases after an intrauterine operation. CI, confidence interval; df, degrees of freedom; M-H, Mantel-Haenszel.
Figure 7.
Figure 7.
Forest plot of pregnancy rate after an intrauterine operation. CI, confidence interval; df, degrees of freedom; M-H, Mantel-Haenszel.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Vancaillie TG, Garad R. Asherman's syndrome. Aust Nurs J. 2013;20:34–36. - PubMed
    1. Yamamoto N, Takeuchi R, Izuchi D, Yuge N, Miyazaki M, Yasunaga M, Egashira K, Ueoka Y, Inoue Y. Hysteroscopic adhesiolysis for patients with Asherman's syndrome: Menstrual and fertility outcomes. Reprod Med Biol. 2013;12:159–166. doi: 10.1007/s12522-013-0149-x. - DOI - PMC - PubMed
    1. Salazar CA, Isaacson K, Morris S. A comprehensive review of Ashermanʼs syndrome. Curr Opin Obstet Gynecol. 2017;29:249–256. doi: 10.1097/GCO.0000000000000378. - DOI - PubMed
    1. Mehedintu C, Ionescu O, Rotaru AM, Antonovici M, Plotogea M, Berceanu C, Vladareanu S, Bratila E. Asherman's syndrome after an uncomplicated cesarian section. Gineco. 2016;12:166–168.
    1. Friedman A, DeFazio J, DeCherney A. Severe obstetric complicantions after aggressive treatment of asherman syndrome. Obstet Gynecol. 1986;67:864–867. doi: 10.1097/00006250-198606000-00025. - DOI - PubMed